quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:26·71d
SECFiling
VivoSim Labs Inc. logo

SEC Form 10-Q filed by VivoSim Labs Inc.

VIVS· VivoSim Labs Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • VIVS
    VivoSim Labs Inc.
    Health Care

Related

  • SEC20d
    VivoSim Labs Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
  • SEC21d
    SEC Form 424B4 filed by VivoSim Labs Inc.
  • PR23d
    VivoSim Announces Pricing of up to a $4 Million Public Offering
  • SEC23d
    SEC Form EFFECT filed by VivoSim Labs Inc.
  • SEC24d
    Amendment: SEC Form S-1/A filed by VivoSim Labs Inc.
  • SEC27d
    SEC Form S-1 filed by VivoSim Labs Inc.
  • PR31d
    VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs
  • PR52d
    VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022